EUVIMEDEUVIMED entdecken
Crossref

Are DEA‐waivered buprenorphine prescribers colocated with behavioral health clinicians?

Lisa de Saxe Zerden iD, Connor Sullivan, Evan Galloway, Erica L Richman, Maria G Gaiser, Brianna Lombardi

The American Journal on Addictions · 2023

DOI: 10.1111/ajad.13462 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The American Journal on Addictions, 2023. Verfasst von Lisa de Saxe Zerden und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Social Work, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. Hauptthemen laut MEDLINE: Buprenorphine, Opioid-Related Disorders, Physicians, Psychiatry. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: HRSA HHS, Health Resources and Services Administration.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives Medication for opioid use disorder (MOUD) in primary care includes a combination of medication, behavioral therapy, and/or other psychosocial services. This study assessed rates of colocation between waivered prescribers and behavioral health clinicians across the United States to understand if rates varied by provider type and geographic indicators.

Methods

Data from the DEA‐Drug Addiction Treatment Act of 2000 provider list as of March 2022 and the National Plan and Provider Enumeration System's National Provider Identifier database were gathered, cleaned, and formatted in Stata. Data were geocoded with ESRI StreetMap® database and ArcGIS software. Covariates at individual, county, and state levels were examined and compared. Chi‐square statistics and a mixed‐effects logistic regression were analyzed.

Results

The sample ( N = 71, 292 prescribers) included physicians (64%), nurse practitioners (29%), and physician assistants (7%). About 48% of prescribers were colocated with a behavioral health clinician. Physicians were the least likely to be colocated (47%), but differences between provider types were modest. We observed significant geographic differences in provider colocation by provider type. Mixed effects logistic regression identified significant predictors of colocation at individual, county, and state levels. Discussion and Conclusions Optimally distributing the workforce providing MOUD is necessary to broadly ensure the provision of comprehensive MOUD care based on practice guidelines. Scientific Significance Less than half of all waivered prescribers, outside of hospitals, are colocated with behavioral health clinicians. Findings offer greater clarity on where integrated MOUD is occurring, among which types of providers, and where it needs to be expanded to increase MOUD uptake.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BuprenorphineOpioid-Related DisordersPhysiciansPsychiatryHumansUnited StatesBehavior TherapyOpiate Substitution Treatment

Substanzen

Buprenorphine

Autor:innen und Institutionen

  • School of Social Work, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Cecil G. Sheps Center for Health Services Research, UNC Behavioral Health Workforce Research Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Department of Family Medicine, School of Social Work, Cecil G. Sheps Center for Health Services Research, UNC Behavioral Health Workforce Research Center, University of North Carolina at Chapel Hill, Chapel Hill, North…

ORCID-Profile: Lisa de Saxe Zerden

Förderung

  • HRSA HHS
  • Health Resources and Services Administration

Zitieren

APA

Zerden, L. S., Sullivan, C., Galloway, E., Richman, E. L., Gaiser, M. G., & Lombardi, B. (2023). Are DEA‐waivered buprenorphine prescribers colocated with behavioral health clinicians?. The American Journal on Addictions. https://doi.org/10.1111/ajad.13462

Vancouver

Zerden LS, Sullivan C, Galloway E, Richman EL, Gaiser MG, Lombardi B. Are DEA‐waivered buprenorphine prescribers colocated with behavioral health clinicians?. The American Journal on Addictions. 2023. doi:10.1111/ajad.13462

BibTeX
@article{Zerden2023,
  author = {Zerden, Lisa de Saxe and Sullivan, Connor and Galloway, Evan and Richman, Erica L and Gaiser, Maria G and Lombardi, Brianna},
  title = {Are DEA‐waivered buprenorphine prescribers colocated with behavioral health clinicians?},
  journal = {The American Journal on Addictions},
  year = {2023},
  doi = {10.1111/ajad.13462}
}
Kostenlos starten →